StonvexLoading…
StonvexStonvexStonvexCore line items from ESNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.26B | $1.24B | $1.11B | $1.00B |
Operating Income | $821.86M | $855.49M | $823.00M | $988.19M |
Net Income | $689.97M | $729.40M | $696.39M | $831.35M |
EPS (Diluted) | $6.90 | $6.85 | $6.50 | $7.72 |
Total Assets | $7.44B | $7.11B | $6.43B | $5.72B |
Total Liabilities | $1.68B | $1.51B | $1.32B | $1.26B |
Cash & Equivalents | $123.05M | $131.48M | $141.79M | $81.24M |
Free Cash Flow OCF − CapEx | $848.69M | $854.77M | $759.00M | $584.84M |
Shares Outstanding | 95.46M | 105.02M | 106.60M | 107.68M |